Catch up on the top radiology content of the past week.
|Articles|April 15, 1998
Premier issues nuclear group buy
ADAC Laboratories of Milpitas, CA, and Siemens Medical Systems of Hoffman Estates, IL, have been named the preferred vendors in a dual-source group buy of nuclear medicine equipment issued by group purchasing organization Premier. Premier members are
Advertisement
ADAC Laboratories of Milpitas, CA, and Siemens Medical Systems of Hoffman Estates, IL, have been named the preferred vendors in a dual-source group buy of nuclear medicine equipment issued by group purchasing organization Premier. Premier members are expected to purchase at least $20 million in equipment from the two companies, according to Pam Parker, director of group buys at the San Diego-based GPO.
Premier selected ADAC and Siemens after surveys of Premier members indicated that the two companies were the highest favored gamma camera vendors, Parker said. Premier members have until mid-May to issue purchase orders that will allow them to lock in the pricing discounts reached under agreement with ADAC and Siemens. Some 62 Premier hospitals have indicated that they are interested in participating in the group buy.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5